Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

Presentation TCT 2024

TCT 329: Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

Presenter: Sem Rikken

October 30, 2024

Presentation TCT 2024

TCT 707: Percutaneous Renal Denervation in the Management of Kidney-Related Pain Syndromes: A Case Series

Presenter: Kari Saville

October 30, 2024

Presentation TCT 2024

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Presenter: Raymond Townsend

October 29, 2024

Presentation TCT 2024

Debate Con: RDN Will Ultimately Be a Niche Therapy

Presenter: Andrew Sharp

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Presenter: Michael Bloch

October 29, 2024

Presentation TCT 2024

What Evaluation is Required for Patient Selection for RDN?

Presenter: Naomi Fisher

October 29, 2024

Presentation TCT 2024

TCT 597: Evaluation of Renal Functional Reserve in Patients With Coronary Microvascular Dysfunction and Preserved Renal Function

Presenter: Kyriakos Dimitriadis

October 29, 2024

Presentation TCT 2024

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

Presenter: Pamela Ropski

October 29, 2024

Presentation TCT 2024

TCT 824: TAVI on Coronary Guidewires: Free-Contrast Technique in Patients With Moderate to Severe Renal Impairment

Presenter: Iulia Tustiu

October 29, 2024

Presentation TCT 2024

What’s Next - Going into 2025

Presenter: Vijay Iyer

October 28, 2024

Presentation TCT 2024

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Getting Started: Establishing a Patient Care Pathway

Presenter: Matheen Khuddus

October 28, 2024

Presentation TCT 2024

Science of Ultrasound RDN

Presenter: Michael Joner

October 28, 2024

Presentation TCT 2024

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Presenter: Raven Voora

October 28, 2024

Presentation TCT 2024

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Presenter: Michael Weber

October 28, 2024

Presentation TCT 2024

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Presenter: Lucas Lauder

October 28, 2024

Advertisement

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

TCT 329: Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

TCT 707: Percutaneous Renal Denervation in the Management of Kidney-Related Pain Syndromes: A Case Series

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Debate Con: RDN Will Ultimately Be a Niche Therapy

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

What Evaluation is Required for Patient Selection for RDN?

TCT 597: Evaluation of Renal Functional Reserve in Patients With Coronary Microvascular Dysfunction and Preserved Renal Function

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

TCT 824: TAVI on Coronary Guidewires: Free-Contrast Technique in Patients With Moderate to Severe Renal Impairment

What’s Next - Going into 2025

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Getting Started: Establishing a Patient Care Pathway

Science of Ultrasound RDN

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content